期刊文献+

双歧三联活菌联合熊去氧胆酸对肝硬化患者的肝功能及血清降钙素原水平的影响

Effect of bifid triple viable bacteria combined with ursodeoxycholic acid on liver function and serum procalcitonin level in patients with liver cirrhosis
原文传递
导出
摘要 目的:观察双歧三联活菌联合熊去氧胆酸对肝硬化患者的肝功能及血清降钙素原水平的影响。方法:58例肝硬化患者,按照随机数字表法分为观察组(n=30)和对照组(n=28),2组在常规治疗基础上,对照组采用双歧三联活菌(3粒,2次/d)治疗,观察组采用双歧三联活菌联合熊去氧胆酸(250 mg,3次/d)治疗。1个月后观察2组治疗疗效、治疗前后肝功能、凝血功能,Child-Pugh评分、降钙素原(PCT)水平。结果:治疗后,观察组总有效率显著高于对照组(P<0.01);ALT、AST、TBil、I-Bil、DBIL水平均显著低于对照组(P<0.01);PTA显著高于对照组(P<0.01);PT、APTT水平显著低于对照组(P<0.01);Child-Pugh评分、PCT水平显著低于对照组(P<0.01)。结论:双歧三联活菌联合熊去氧胆酸可有效改善肝硬化患者的临床症状,可降低血清PCT水平,降低血生化值,改善肝功能和凝血功能。 Objective: To observe the effect of Bifid Triple Viable Bacteria combined with ursodeoxycholic acid on liver function and serum procalcitonin level in patients with liver cirrhosis. Methods: Fifty-eight cases of Cirrhosis. According to random number table, those patients were divided into the observation group(n=30) and the control group(n=28). On the basis of routine treatment, The control group was treated with Bifid Triple Viable Bacteria(3 capsules, twice a day), while the observation group treated with Bifid Triple Viable Bacteria combined with ursodeoxycholic acid(250 mg, 3 times a day). One month later, the therapeutic effect, liver function, coagulation function, Child-Pugh score and procalcitonin(PCT) level of the two groups were observed before and after treatment. Results: After treatment, The total remission rate in the observation group was significantly higher the control group(P<0.05). The levels of ALT, AST, TBil, I-Bil, DBIL were significantly lower than the control group(P<0.01). PTA was significantly higher than the control group(P<0.01). The levels of PT and APTT were significantly lower than the control group(P<0.01). Child-Pugh score and PCT levels were significantly lower than the control group(P<0.01). Conclusion: Bifid Triple Viable Bacteria combined with ursodeoxycholic acid can effectively improve the clinical symptoms of patients with liver cirrhosis, reduce serum procalcitonin level, reduce blood biochemical value, improve liver function and coagulation function.
作者 赵宝生 高美丽 贺新竹 赵严亮 张龙 ZHAO Baosheng;GAO Meili;HE Xinzhu;ZHAO Yanliang;ZHANG Long(Department of Infectious Disease,Hebei Petro China Central Hospital,Langfang,065000,China)
出处 《中国中西医结合消化杂志》 CAS 2021年第2期90-93,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 2019年度河北省医学科学研究课题项目(No:20191734)。
关键词 双歧三联活菌 熊去氧胆酸 肝硬化 肝功能 血清降钙素原 bifidobacteria ursodeoxycholic acid cirrhosis liver function serum procalcitonin
  • 相关文献

参考文献8

二级参考文献115

  • 1张嘉,吕德超.肠道屏障功能监测方法的现状及进展[J].中国急救复苏与灾害医学杂志,2007,2(10):630-633. 被引量:13
  • 2施健,刘苏,陈伟忠,曾欣,陈岳祥,杨秀疆,谢渭芬.中等剂量熊去氧胆酸治疗原发性胆汁性肝硬化的系统评价[J].中华消化杂志,2005,25(6):355-358. 被引量:30
  • 3白顺滟,彭燕.酒精性肝病与肠道屏障功能改变[J].实用肝脏病杂志,2006,9(3):178-182. 被引量:17
  • 4樊宏伟,范亚硕,丁小琳.熊去氧胆酸治疗原发性胆汁性肝硬化的疗效分析[J].实用肝脏病杂志,2006,9(4):245-246. 被引量:6
  • 5中华医学会传染病寄生虫病学会修订.病毒性肝炎防治方案[J].中华传染病学杂志,2000,19(6):241-243.
  • 6Rimola A,García-Tsao G,Navasa M,et al.Diagnosis,treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document.International Ascites Club[J].J Hepatol,2000,32(2):142-153.
  • 7Hosoda N,Nishi M,Nakagawa M,et al.Structual and functional alterations in the gut of parenterally or enterally fed rats[J].J Surg Res,1989,47(2):129-133.
  • 8HYI-IROGLOU P, SNOVER DC, ALVES V, et al. Beyond " cirrhosis" : a proposal from the International Liver Pathology Study Group[J]. Am J Clin Pathol, 2012, 137(1 ): 5 -9.
  • 9MANOLAKOPOULOS S, TRIANTOS C, THEODOROPOULOS J, et al. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg -negative chronic hepatitis B and significant portal hypertension [ J ]. J Hepatol, 2009, 51 (3): 468 -474.
  • 10MARCELLIN P, GANE E, BUTI M, et al. Regression of cir- rhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5 -year open -label follow -up study [J]. Lancet, 2013, 381(9865):468-475.

共引文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部